The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community   Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics...
0 Comments 0 Shares